Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Buy
53
MPW Quote, Financials, Valuation and Earnings
Last price:
$6.04
Seasonality move
:
2.58%
Day range:
$6.00 - $6.21
52-week range:
$3.51 - $6.55
Dividend yield:
8.94%
P/E ratio:
--
P/S ratio:
3.64x
P/B ratio:
0.75x
Volume:
7.6M
Avg. volume:
11.8M
1-year change:
28.51%
Market cap:
$3.6B
Revenue:
$995.5M
EPS (TTM):
-$4.03
Analysts' Opinion
-
Consensus RatingMedical Properties Trust has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 5 Hold ratings, and 1 Sell rating.
-
Price Target DownsideAccording to analysts' consensus price target of $5.50, Medical Properties Trust has an estimated downside of -8.94% from its current price of $6.04.
-
Price Target UpsideAccording to analysts, the highest upside price target is $9.00 representing -100% upside increase from its current price of $6.04.
Fair Value
-
According to the consensus of 6 analysts, Medical Properties Trust has -8.94% downside to fair value with a price target of $5.50 per share.
MPW vs. S&P 500
-
Over the past 5 trading days, Medical Properties Trust has overperformed the S&P 500 by 2.57% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Medical Properties Trust does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Medical Properties Trust revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Medical Properties Trust reported revenues of $231.8M.
Earnings Growth
-
Medical Properties Trust earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Medical Properties Trust reported earnings per share of -$0.69.
Enterprise value:
12.1B
EV / Invested capital:
--
Price / LTM sales:
3.64x
EV / EBIT:
31.39x
EV / Revenue:
12.20x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
49.47x
Price / Operating cash flow:
14.77x
Enterprise value / EBITDA:
14.45x
Gross Profit (TTM):
$968.3M
Return On Assets:
-14.82%
Net Income Margin (TTM):
-242.11%
Return On Equity:
-39.12%
Return On Invested Capital:
-15.37%
Operating Margin:
55.48%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $1.5B | $871.8M | $995.5M | -$122.4M | $231.8M | |
| Gross Profit | $1.5B | $830.2M | $968.3M | -$125.7M | $222.1M | |
| Operating Income | $1B | $81.3M | $386.8M | -$233.1M | $128.6M | |
| EBITDA | $1.3B | $697.4M | $840.6M | -$120.5M | $2.1B | |
| Diluted EPS | $1.50 | -$0.94 | -$4.03 | -$1.11 | -$0.69 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2B | $1.4B | $1.7B | $1.4B | $1.3B | |
| Total Assets | $16.8B | $20.5B | $19.7B | $18.3B | $14.3B | |
| Current Liabilities | $640.3M | $2.2B | $1.6B | $2B | $845.4M | |
| Total Liabilities | $9.5B | $12.1B | $11.1B | $10.7B | $9.5B | |
| Total Equity | $7.3B | $8.4B | $8.6B | $7.6B | $4.8B | |
| Total Debt | $8.9B | $11.3B | $10.3B | $10.1B | $8.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $739M | $505.8M | $245.5M | $135.4M | $76.7M | |
| Cash From Investing | $396.1M | $517.6M | $1.3B | $170.2M | $91.7M | |
| Cash From Financing | -$1.3B | -$1B | -$1.5B | -$402.7M | -$99.8M | |
| Free Cash Flow | $739M | $505.8M | $245.5M | $135.4M | $76.7M | |
MPW
Sector
Market Cap
$3.6B
$1B
Price % of 52-Week High
92.21%
81.16%
Dividend Yield
8.94%
3.29%
Shareholder Yield
--
3.37%
1-Year Price Total Return
28.51%
-0.5%
Beta (5-Year)
1.324
0.886
Dividend yield:
8.94%
Annualized payout:
$0.46
Payout ratio:
-13.32%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$6.07
200-day SMA
Buy
Level
$4.81
Bollinger Bands (100)
Buy
Level
3.96 - 5.4
Chaikin Money Flow
Sell
Level
-22.5M
20-day SMA
Buy
Level
$5.94
Relative Strength Index (RSI14)
Buy
Level
60.47
ADX Line
Buy
Level
43.88
Williams %R
Neutral
Level
-40.8163
50-day SMA
Buy
Level
$5.18
MACD (12, 26)
Buy
Level
0.28
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Sell
Level
-575.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.0096)
Sell
CA Score
(Annual)
Level (-0.8751)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (0.8801)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Medical Properties Trust Inc acquires and develops net-leased healthcare facilities. Its investments in healthcare real estate, other loans, and any investments in tenants are considered a single reportable segment. The group's geographic areas are the United States, the United Kingdom, and All other countries.
Stock Forecast FAQ
In the current month, MPW has received 0 Buy ratings 5 Hold ratings, and 1 Sell ratings. The MPW average analyst price target in the past 3 months is $5.50.
-
Where Will Medical Properties Trust Stock Be In 1 Year?
According to analysts, the consensus estimate is that Medical Properties Trust share price will drop to $5.50 per share over the next 12 months.
-
What Do Analysts Say About Medical Properties Trust?
Analysts are divided on their view about Medical Properties Trust share price and where it will be in the next 12 months. The majority of analysts rate the stock a Sell. However, a smaller subset of analysts suggest that Medical Properties Trust is a Buy and believe this share price will rise from its current level to $9.00.
-
What Is Medical Properties Trust's Price Target?
The price target for Medical Properties Trust over the next 1-year time period is forecast to be $5.50 according to 6 Wall Street analysts, 0 of them rate the stock a Buy, 1 rates the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is MPW A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Medical Properties Trust is a Hold. 5 of 6 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of MPW?
You can purchase shares of Medical Properties Trust via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Medical Properties Trust shares.
-
What Is The Medical Properties Trust Share Price Today?
Medical Properties Trust was last trading at $6.04 per share. This represents the most recent stock quote for Medical Properties Trust. Yesterday, Medical Properties Trust closed at $6.04 per share.
-
How To Buy Medical Properties Trust Stock Online?
In order to purchase Medical Properties Trust stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Buffett Sell the S&P 500?
Warren Buffett has always been an advocate of investing in…
Will SoundHound AI Stock Recover?
SoundHound AI (NASDAQ:SOUN) is a leading maker of artificial intelligence…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
AJINY alert for Mar 29
Ajinomoto [AJINY] is up 99.61% over the past day.
Buy
69
AGX alert for Mar 29
Argan [AGX] is up 19.83% over the past day.
Sell
24
AIR alert for Mar 29
AAR [AIR] is down 16.36% over the past day.
